Stay cool with the latest edition of "Weekly Update!" We have not one but two STAT investigations - plus, biotech updates, Fauci on the First Opinion podcast, Elmo and friends, and much more! Read now ⬇
STAT
Internet News
Boston, Massachusetts 31,395 followers
Reporting from the frontiers of health and medicine.
About us
Reporting from the frontiers of health and medicine We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all. Get access to exclusive content: http://www.statnews.com. Follow us on Twitter @statnews and on Facebook at facebook.com/statnews
- Website
-
http://www.statnews.com
External link for STAT
- Industry
- Internet News
- Company size
- 51-200 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Specialties
- news, science news, medicine, health, biotech, pharma, health tech, covid, hospitals, and business
Locations
-
Primary
1 Exchange Pl
Boston, Massachusetts 02109, US
Employees at STAT
Updates
-
CTE can only be diagnosed after death. But Ann McKee and her colleagues published new research this year that could eventually help identify the condition while people are still alive. She spoke to STAT in a new Q/A. https://trib.al/HZi08Eo
The biggest misconception about CTE, according to a leading brain trauma expert
https://www.statnews.com
-
Nominations for the 2024 #STATWunderkinds close tomorrow! Last call to make a submission: https://trib.al/S7F6AMi
-
-
Medicare regulators proposed new codes that support payment for digital mental health treatments. https://trib.al/kycqy5h
Medicare proposes to cover some digital therapies in a breakthrough for health tech firms
https://www.statnews.com
-
Cancer studies fail all the time. But it’s far less common, and quite alarming, to see a study in which the experimental drug showed “reduced efficacy” (Roche’s terminology) in relation to a comparator, Adam Feuerstein writes. Simply stated: The patients fared meaningfully worse. Read more in Adam’s Biotech Scorecard. https://trib.al/J4lnm0l
Roche’s TIGIT study was a bust. What's the outlook for its next big bet?
https://www.statnews.com
-
Pfizer plans to advance a new, once-a-day formulation of its experimental obesity drug danuglipron, meant to be a pill version in the same class as Wegovy and Zepbound. https://trib.al/JzUXv7i
Pfizer says it will advance once-daily GLP-1 pill after all
https://www.statnews.com
-
The FDA rejected Novo Nordisk’s weekly insulin for the treatment of diabetes. https://trib.al/fJZb1j8
Novo Nordisk’s weekly insulin rejected by FDA
https://www.statnews.com
-
The Federal Trade Commission plans to sue the three largest PBMs. Here's why: https://trib.al/psBpzZC
FTC plans to sue PBMs over the high cost of insulin and other medicines
https://www.statnews.com
-
The federal government will not modify regulations that dictate how hospitals publish their prices for consumers. https://trib.al/dWyrGEG
Biden administration ignores calls to bolster hospital price transparency
https://www.statnews.com
-
Fourth time’s the charm? Sanford Health hopes to shake off a run of failed deals by snapping up a $3 billion Wisconsin health system. https://trib.al/33w87Qi
Sanford Health aims to shake off a run of failed deals by snapping up a $3 billion Wisconsin health system
https://www.statnews.com